Kip Lyche
University of California, San Diego
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kip Lyche.
Gastroenterology | 1995
Douglas Simon; John P. Cello; Jorge E. Valenzuela; Richard Levy; Gordon Dickerson; Richard Goodgame; Michael D. Brown; Kip Lyche; W. Jeffrey Fessel; James Grendell; C. Mel Wilcox; Nezam H. Afdhal; Ronald Fogel; Vonda Reeves-Darby; John J. Stern; Owen J. Smith; Frank M. Graziano; Douglas Pleakow; Timothy P. Flanigan; Timothy T. Schubert; Mark O. Loveless; Larry Eron; Paul Basuk; Maurizio Bonacini; Jan M. Orenstein
BACKGROUND/AIMS Diarrhea is a significant problem in patients with acquired immunodeficiency syndrome (AIDS). The aim of this study was to determine octreotide effectiveness in refractory AIDS-associated diarrhea. METHODS In a 3-week protocol, 129 patients with a stool weight of > 500 g/day despite standard antidiarrheal therapy were randomized to receive octreotide or placebo (3:2 ratio). Octreotide dose was increased 100 micrograms weekly to a maximum of 300 micrograms three times a day based on weekly 72-hour stool collections. Subsequently, patients received open-label octreotide at doses of up to 500 micrograms three times a day. RESULTS A 30% decrease in stool weight defined response. After 3 weeks, 48% of octreotide- and 39% of placebo-treated patients had responded (P = 0.43). At 300 micrograms three times a day, 50% of octreotide- and 30.1% of placebo-treated patients responded (P = 0.12). At a baseline stool weight of 1000-2000 g/day, 57% of octreotide- and 25% of placebo-treated patients responded (P = 0.06). Response rates based on CD4 counts, diarrhea duration, body weight, human immunodeficiency virus risk factor, and presence or absence of pathogens showed no benefit of octreotide. Adverse events were more frequent in the octreotide-treated group. CONCLUSION In the doses studied, octreotide was not more effective than placebo in patients with refractory AIDS-associated diarrhea. This lack of effectiveness may be attributable to inadequate sample size, doses, and duration of study treatment.
Journal of General Internal Medicine | 1993
Sally G. Tamayo; Leland S. Rickman; W. Christopher Mathews; Steven C. Fullerton; Angie E. Bartok; James T. Warner; W David FeigalJr.; Dayna G. Arnstein; Natalie S. Callandar; Kip Lyche; Mark H. Shapiro; Jack C. Yang
Objective: To determine the reliability and validity of various physical diagnostic techniques (including three methods of palpation and three methods of percussion) in detecting ultrasonographically identified splenomegaly.Design: Prospective, double-blind study.Setting: University hospital.Patients: Twenty-seven hospitalized male patients with suspected human immunodeficiency virus (HIV) infection.Interventions: Three methods of palpation (bimanual, ballottement, and palpation from above) and three methods of percussion (as described by Nixon, Castell, and Barkun et al.) were performed on each patient by eight examiners. Splenic ultrasonography was performed within 96 hours of admission.Measurements and main results: The prevalence of splenomegaly by ultrasonography (defined as a spleen ≥ 13 cm on the longitudinal scan) in this population was 33.3%. The sensitivity and specificity of each method of palpation and percussion varied by examiner. The ranges of sensitivity across examiners for the three methods of palpation and the three methods of percussion were 0%–64.3% and 7.7%–75%, respectively. The ranges of specificity across examiners for the three methods of palpation and the three methods of percussion were 50%–100% and 60%–100%, respectively. Likelihood ratios pooled across observers revealed that for palpation, palpation from above, and percussion, Castell’s method had the highest likelihood ratios [LR=2.66 and 1.97, respectively; 95% CI=1.52–4.64 and 1.22–3.19, respectively]. A combination of tests (either palpation or percussion) increased the diagnostic accuracy.Conclusion: Physical diagnostic techniques for the detection of splenomegaly are relatively insensitive but specific. In this study there was high interobserver variability, which did not appear to be associated to the level of experience. Combining tests increases diagnostic accuracy.
Medicine | 1996
Sammy Saab; Leland S. Rickman; Kip Lyche
We identified 54 patients with AIDS and ascites seen over a 4.5-year period at a university hospital. This retrospective study is the largest reported series of patients with AIDS and ascites. Patients with AIDS who are evaluated for ascites should be stratified by the CD4 + cell count and the presence or absence of portal hypertension based upon the serum-ascites albumin gradient and clinical presentation. Awareness of possible surgery-related causes of ascites is crucial, as these patients may not manifest the usual signs and symptoms of peritonitis or abdominal catastrophes seen in immunocompetent hosts. Patients with evidence of portal hypertension due to hepatic cirrhosis and an elevated ascitic neutrophil count should be suspected to be infected with common bacterial pathogens associated with peritonitis unless the CD4 + cell count is below 50 cells/mm3. When the CD4 + cell count declines below this threshold, infections due to Mycobacterium avium complex, cytomegalovirus, and other opportunistic infections should be considered.
The American Journal of Gastroenterology | 2000
Arjun Venkataramani; Cynthia Behling; R Rond; C Glass; Kip Lyche
We report a case series of 13 adult hemophiliacs with serological evidence of hepatitis C who underwent percutaneous liver biopsies without major complications. We also briefly review the recent literature on safety of liver biopsies in this population, and conclude that these patients may be safely biopsied using appropriate precautions regardless of the severity of hemophilia.
Gastroenterology | 1997
Karl Houglum; Arjun Venkataramani; Kip Lyche; Mario Chojkier
Hepatology | 1988
Mario Chojkier; Kip Lyche; Michael Filip
Hepatology | 1999
E. Jenny Heathcote; Stephen P. James; Kevin D. Mullen; S. C. Hauser; H. Rosenblate; Donald Albert; Robert J Bailey; Vincent G. Bain; K. Bala; Luis A. Balart; Herbert L. Bonkovsky; Martin Black; William M. Cassidy; J. Donovan; M. Ehrinpreis; Gregory T. Everson; Saya V. Feinman; Robert T. Foust; H. Fromm; John C. Hoefs; E. B. Hollinger; Donald M. Jensen; Paul G. Killenberg; Emmet B. Keeffe; Edward L. Krawitt; Samuel S. Lee; William M. Lee; D. J. VanLeeuwen; H. R. Lesesne; Kip Lyche
The American Journal of Gastroenterology | 1997
Arjun Venkataramani; Cynthia Behling; Kip Lyche
The American Journal of Gastroenterology | 2000
Arjun Venkataramani; Cynthia Behling; R Rond; C Glass; Kip Lyche
Hepatology | 2003
Furqaan Ahmed; Ira M. Jacoboon; Steve T. Chen; Simon Cofrancesco; Jeffrey Cooley; Michael Demicco; Bradley Freilich; Brian Hudes; Jonathan Jensen; Arnold Levin; Kip Lyche; Jonathan McCone; Howard P. Monsour; Craig J. Peine; Neville R. Pimstone; Thomas Rosenfield; Robert Strauss; Kusum Stokes; Norah A. Terrault; Naoky Tsai; Ronald B. Wasserman; Graham Woolf; Robert S. Brown; Clifford A. Brass